:::

詳目顯示

回上一頁
題名:Unmet Needs for the Management of Depression
書刊名:Taiwanese Journal of Psychiatry
作者:Pan, Yi-ju
出版日期:2019
卷期:33:3
頁次:頁122-124
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:3
  • 點閱點閱:4
期刊論文
1.Mojtabai, R.、Olfson, M.、Sampson, N. A.、Jin, R.、Druss, B.、Kessler, R. C.(2011)。Barriers to mental health treatment: results from the National Comorbidity Survey Replication。Psychological Medicine,41,1751-1761。  new window
2.Weissman, M. M.、Bland, R. C.、Canino, G. J.、Faravelli, C.、Greenwald, S.、Hwu, H. G.、Joyce, P. R.(1996)。Cross-National Epidemiology of Major Depression and Bipolar Disorder。Journal of the American Medical Association,276,293-299。  new window
3.Rush, A. J.、Trivedi, M. H.、Wisniewski, S. R.、Nierenberg, A. A.、Stewart, J. W.、Warden, D.、Niederehe, G.(2006)。Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a Star* D report。American Journal of Psychiatry,163(11),1905-1917。  new window
4.Dunner, David L.(20130600)。Treatment-resistant Depression。Taiwanese Journal of Psychiatry,27(2),110-120。new window  new window
5.Trivedi, M. H.、Rush, A. J.、Wisniewski, S. R.(2006)。Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice。Am J Psychiatry,163,28-40。  new window
6.陳奕安、邱一航、沈武典(20180900)。Drug Augmentation for Treatment-refractory Major Depressive Disorder。Taiwanese Journal of Psychiatry,32(3),188-199+a2。new window  new window
7.Pan, Y. J.、Liu, S. K.、Yeh, L. L.(2013)。Factors affecting early attrition and later treatment course of antidepressant treatment of depression in naturalistic settings: an 18‑month nationwide population‑based study。J Psychiatr Res,47,916-925。  new window
8.Simon, G. E.、Goldberg, D. P.、Von Korff, M.(2002)。Understanding cross-national differences in depression prevalence。Psychol Med,32,585-594。  new window
9.Chang, S. M.、Hahm, B. J.、Lee, J. Y.(2008)。Cross‑national difference in the prevalence of depression caused by the diagnostic threshold。J Affect Disord,106,159-167。  new window
10.Lee, S.、Tsang, A.、Zhang, M. Y.(2007)。Lifetime prevalence and inter-cohort variation in DSM‑IV disorders in metropolitan China。Psychol Med,37,61-71。  new window
11.Naganuma, Y.、Tachimori, H.、Kawakami, N.(2006)。Twelve‑month use of mental health services in four areas in Jaapan: findings from the world mental health Japan survey 2002‑2003。Psychiatry Clin Neurosci,60,240-248。  new window
12.Ballenger, J. C.(1999)。Clinical guidelines for establishing remission in patients with depression and anxiety。J Clin Psychiatry,60(Suppl 16),29-34。  new window
13.Judd, L. L.、Paulus, M. J.、Schettler, P. J.(2000)。Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?。Am J Psychiatry,157,1501-1504。  new window
14.Empana, J. P.、Sykes, D. H.、Luc, G.(2005)。Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study of myocardial infarction (PRIME)。Circulation,111,2299-2305。  new window
15.Greden, J. F.(2013)。Workplace depression: personalize, partner, or pay the price。Am J Psychiatry,170,578-581。  new window
16.Thase, M. E.(2010)。Unmet needs in the management of major depressive disorder。CNS Spectr,15,4-7。  new window
17.Pan, Y. J.、Knapp, M.、McCrone, P.(2014)。Impact of initial treatment outcome on long‑term costs of depression: a 3-year nationwide follow‑up study in Taiwan。Psychol Med,44,1147-1158。  new window
18.Zimmerman, M.、McGlinchey, J. B.、Posternak, M. A.(2006)。How should remission from depression be defined? the depressed patient's perspective。Am J Psychiatry,163,148-150。  new window
19.Sheehan, D. V.、Nakagome, K.、Asami, Y.(2017)。Restoring function in major depressive disorder: a systematic review。J Affect Disord,215,299-313。  new window
20.Baune, B. T.、Christensen, M. C.(2019)。Differences in perceptions of major depressive disorder symptoms and treatment priorities between patients and health care providers across the acute, post‑acute, and remission phases of depression。Front Psychiatry,10。  new window
21.Anderson, I. M.(2018)。We all know what we mean by treatment‑resistant depression - Don't we?。Br J Psychiatry,212,259-261。  new window
22.McAllister-Williams, R. H.、Christmas, D. M.、Cleare, A. J.(2018)。Multiple‑therapy‑resistant major depressive disorder: a clinically important concept。Br J Psychiatry,212,274-278。  new window
23.Hwu, H. G.、Chang, I. H.、Yeh, E. K.、Chang, C. J.、Yeh, L. L.(1966)。Major Depressive Disorder in Taiwan Defined by the Chinese Diagnostic Interview Schedule。Journal of Nervous and Mental Disease,184(8),497-502。  new window
24.Liao, S. C.、Chen, W. J.、Lee, M. B.、Lung, F. W.、Lai, T. J.、Liu, C. Y.、Chen, C. C.(2012)。Low prevalence of major depressive disorder in Taiwanese adults: Possible explanations and implications。Psychological Medicine,42(6),1227-1237。  new window
25.Compton, W. M. III、Helzer, J. E.、Hwu, H. G.、Yeh, E. K.、McEvoy, L.、Tipp, J. E.、Spitznagel, E. L.(1991)。New methods in cross-cultural Psychiatry: Psychiatric illness in Taiwan and the United States。American Journal of Psychiatry,148(12),1697-1704。  new window
26.Kessler, R. C.、Berglund, P.、Demler, O.、Jin, R.、Koretz, D.、Merikangas, K. R.、Rush, A. J.、Walters, E. E.、Wang, P. S.(2003)。The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R)。Journal of the American Medical Association,289,3095-3105。  new window
27.Ickovics, J. R.、Hamburger, M. E.、Vlahov, D.、Schoenbaum, E. E.、Schuman, P.、Boland, R. J.、Moore, J.(2001)。Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study。JAMA: The Journal of the American Medical Association,285(11),1466-1474。  new window
圖書
1.American Psychiatric Association(2010)。Practice Guideline for the Treatment of Patients with Major Depressive Disorder。American Psychiatric Association。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
1. The Potential Use of Using the Psychological Side Effects of Antidepressants in Treating Cancer Patients
2. Interpersonal Therapy Group for Middle-aged Depressive Patients: A Pilot Study
3. Long-term Safety, Efficacy, Treatment Satisfaction, and Impact on Healthcare Service Use of Paliperidone Palmitate One-month Intramuscular Formulation in Patients with Recent-onset Schizophrenia in Taiwan: A Subgroup Analysis of an Asia-Pacific, 18-month, Phase 3b Study
4. Risk of Developing Migraine among Patients with Posttraumatic Stress Disorder: A Nationwide Longitudinal Study
5. A History of Mental Health Care in Japan: International Perspectives
6. The Moderator Rôle of Family Support between Depression and Suicidal Ideation: Discrepancy between Male and Female Military Population in Taiwan
7. Avoidable Mortality among Long-stay Patients with Schizophrenia under Different Smoking-restriction Settings
8. A Gene-gene Interaction between the Vascular Endothelial Growth Factor A and Brain-derived Neurotrophic Factor Genes Is Associated with Psychological Distress in the Taiwanese Population
9. Effectiveness of Medical Service Quality Promotion Project for Child and Adolescent Patients with Mental Disabilities and Psychiatric Disorders in Taiwan
10. Banning Paraquat Would Prevent Nearly 200 Deaths from Suicide per Year in Taiwan
11. Risk Factors of Psychiatric Hospitalization of Military Service Persons in Taiwan: Preliminary Results from Unsupervised Clustering Techniques
12. The Correlations between Results of Short-form Wechsler Adult Intelligence Scale-III and Demographic/Clinical Factors in Patients with Schizophrenia: Preliminary Findings
13. Maker Activities in a Psychiatric Day Care Center
14. The Reinforcement Sensitivity of Male Adults with Attention-deficit/Hyperactivity Disorder: The Association with Internet Addiction
15. A Gene-based Analysis of Variants in the Brain-derived Neurotrophic Factor Gene with Psychological Distress in a Taiwanese Population
 
QR Code
QRCODE